Cushing's Disease
Learn about Cushing's Disease (Pituitary-dependent Cushing's Syndrome) diagnosis, including clinical documentation, medical coding, and ACTH-secreting Pituitary Adenoma. Find information on healthcare best practices for Cushing's Syndrome and pituitary adenoma diagnosis codes for accurate medical record keeping. This resource offers guidance for clinicians on diagnosing and documenting Cushing's Disease.
Hormonal disorder caused by prolonged exposure to high cortisol levels, often due to a pituitary tumor.
Weight gain, moon face, fatty hump, thin skin, easy bruising, muscle weakness, fatigue.
Endocrinology clinics, pituitary centers, neurosurgery departments.
ICD-10 Code Families
Complete code families applicable to E24.0
When to use each related code
| Description | When to use |
|---|---|
| Excess cortisol due to pituitary tumor. | Confirmed pituitary adenoma causing hypercortisolism. Use when pituitary is the primary cause. |
| Excess cortisol, non-pituitary cause. | Hypercortisolism with adrenal or ectopic ACTH source. Exclude pituitary etiology first. |
| Cushing-like symptoms, no confirmed hypercortisolism. | Suspected Cushing's with negative tests. Document clinical findings supporting suspicion. |
Best-practice checklist
- ✓Document elevated ACTH levels.
- ✓Confirm pituitary adenoma source.
- ✓Exclude adrenal or ectopic ACTH causes.
- ✓Detail clinical manifestations (e.g., hirsutism, central obesity).
- ✓Record patient response to dexamethasone suppression test.
Common pitfalls to avoid
Confusing ACTH-dependent Cushing's (Cushing's Disease) with other causes of Cushing's Syndrome impacting code selection (E24.0 vs. E24.2).
Lack of documentation specifying pituitary adenoma location and size for accurate coding (D35.2) and CDI queries.
Missing documentation and coding for common comorbidities like hypertension, diabetes, osteoporosis, impacting risk adjustment and quality reporting.
Best-practice tips
- 01Document ACTH levels, source, and imaging for Cushing's Disease coding accuracy.
- 02CDI: Query physician for Cushing's etiology (pituitary vs. other) for ICD-10 specificity.
- 03Ensure medical necessity for pituitary MRI/CT per payer guidelines for compliance.
- 04Code E24.0 for pituitary Cushing's; other Cushing's variants require distinct ICD-10 codes.
- 05Cortisol testing and dexamethasone suppression test results crucial for proper documentation.
Step-by-step checklist
- 1
1. Verify elevated cortisol: 24-hr urine, late-night salivary, or low-dose dexamethasone suppression test.
- 2
2. Confirm ACTH dependence: High plasma ACTH or failure to suppress with high-dose dexamethasone.
- 3
3. Image pituitary: MRI preferred to identify adenoma source.
- 4
4. Document clinical features: Hirsutism, central obesity, moon face, hypertension.
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of Cushing's Disease, a specific form of Cushing's Syndrome caused by an ACTH-secreting pituitary adenoma. Clinical findings include weight gain, particularly central obesity with facial rounding (moon face) and supraclavicular fat pads, as well as proximal muscle weakness and thin skin with easy bruising. The patient also reports hirsutism, menstrual irregularities, and decreased libido. Hypertension, hyperglycemia, and osteoporosis are noted, raising concern for long-term corticosteroid excess. Differential diagnosis includes adrenal adenoma, ectopic ACTH secretion, and exogenous steroid use. Initial laboratory evaluation will include 24-hour urinary free cortisol, late-night salivary cortisol, and low-dose dexamethasone suppression test to confirm hypercortisolism and assess for ACTH dependency. Pituitary MRI with contrast is planned to evaluate for the presence of a pituitary adenoma. If imaging confirms a pituitary lesion, inferior petrosal sinus sampling may be considered to further differentiate pituitary from ectopic ACTH secretion. Treatment options for Cushing's Disease include transsphenoidal surgery, radiation therapy, and medical management with medications such as ketoconazole, metyrapone, or pasireotide to control cortisol levels pending definitive treatment. Patient education regarding the disease process, potential complications, and treatment options was provided. Follow-up is scheduled to review laboratory results and discuss further management based on diagnostic findings. ICD-10 code E24.0 and CPT codes for the planned diagnostic tests and procedures will be documented accordingly for medical billing and coding purposes.
Common questions and answers
How to differentiate Cushing's Disease from other causes of Cushing's Syndrome in a differential diagnosis?+
Differentiating Cushing's Disease (pituitary-dependent Cushing's Syndrome) from other etiologies, such as ectopic ACTH secretion or adrenal tumors, requires a multi-step approach. Start with confirming hypercortisolism through tests like 24-hour urinary free cortisol, late-night salivary cortisol, and low-dose dexamethasone suppression test. If hypercortisolism is present, measure plasma ACTH levels. Elevated ACTH suggests either Cushing's Disease or ectopic ACTH secretion. Distinguishing between these involves further investigations like high-dose dexamethasone suppression test, corticotropin-releasing hormone (CRH) stimulation test, and inferior petrosal sinus sampling (IPSS). If ACTH is suppressed, suspect an adrenal source. Consider implementing a step-wise diagnostic algorithm and imaging studies (MRI of the pituitary, CT of the adrenals and chest/abdomen) to pinpoint the cause. Explore how dynamic testing can play a crucial role in confirming the diagnosis. Consult endocrinology guidelines for comprehensive management strategies.
What are the best practices for interpreting the results of dexamethasone suppression tests in the workup for Cushing's Disease?+
Interpreting dexamethasone suppression tests (DSTs) requires careful consideration of the specific protocol used (low-dose vs. high-dose) and potential confounding factors. In Cushing's Disease (ACTH-secreting pituitary adenoma), the low-dose DST typically fails to suppress cortisol production. A high-dose DST may show some degree of suppression in Cushing's Disease, differentiating it from some cases of ectopic ACTH secretion which typically show no suppression. False-positive results can occur with certain medications (e.g., certain antidepressants, anticonvulsants) and conditions (e.g., depression, alcoholism, acute illness). False-negative results can be seen with mild Cushing's. Correlate DST results with other clinical and biochemical findings, like late-night salivary cortisol and 24-hour urinary free cortisol, for accurate interpretation. Learn more about the impact of medication and co-morbidities on DST results to avoid misdiagnosis.
What are the latest guidelines and recommended treatment options for managing an ACTH-secreting pituitary adenoma causing Cushing's Disease?+
Management of an ACTH-secreting pituitary adenoma, the primary cause of Cushing's Disease, typically begins with transsphenoidal surgery as the first-line treatment. The goal is complete resection of the adenoma, leading to normalization of cortisol levels. For patients who are not surgical candidates or have persistent/recurrent disease, medical therapies targeting cortisol synthesis (e.g., ketoconazole, metyrapone, mitotane) or blocking ACTH receptors (e.g., pasireotide, osilodrostat) may be considered. Radiation therapy, including stereotactic radiosurgery, can also be used as an adjunct or alternative to surgery. Explore how recent advancements in targeted therapies are influencing treatment strategies for Cushing's Disease. Consider implementing a personalized approach based on patient-specific factors and disease severity, consulting current endocrine society guidelines for the most up-to-date recommendations.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.